A tiny implant that releases chemotherapy directly at the site of a cancer tumour is being tested in Abu Dhabi, in a clinical trial that could eventually offer some rectal cancer patients an alternative to surgery that may leave them with a permanent stoma.The first patient has received the investigational MediChip implant at Burjeel Cancer Institute, where US biotechnology company BioSapien is conducting its first-in-human Phase I trial. The…